No large biobanks at national or international level are available for extended genetic analyses, which are necessary to determine gene-related causes of cardiovascular disease in diabetes. This could be remedied by the proposed European Platform for Clinical Research in Diabetes (EPCRD – Chapter 4). It is supposed that multiple genes and their different combinations (as various gene mixtures) participate in development of macrovascular complications. Lack of data from large studies with adequate statistical power prevents clinicians from considering and using genetic information in clinical decisions for proper treatment.

Related concepts
Last update :
This website is created with material from the European Union FP7-funded DIAMAP project (concluded 2010). The content is continually being reviewed and updated as we are undertaking on-going consultation with the diabetes research community. Progress will be indicated on the road maps. You can send comments on the scientific content through the tab on the right 'make a feedback!'.
Send feedback !
Legal pages
Privacy Policy
This site uses cookies to make statistics over visiters. By using our site, you acknowledge that you have read and understand our Privacy Policy, and our Terms of Service. Your use of DIAMAP's website and services is subject to these policies and terms.